Thanks for this information.. I hope the phase 3 trials are as successful. btw... I believe the correct spelling (for the title) should be "anifrolumab."
By downloading this material, I acknowledge that it may be used only for personal use and personal education and that I will accredit RheumNow.com as the source and owner of this material. Commercial use or mass reproduction of this material without permission from RheumNow (info@rheumnow.com) is prohibited.